EP PerMed Newsletter 13 | 03 November 2025

Dear subscribers,

November 2023 marks the launch of the European Partnership for Personalised Medicine. For the past two years, our 60-plus partners have been intensively working to promote the research, innovations and implementation of personalised medicine approaches. Together, we have published seven calls, funded numerous research and innovation projects, and hosted a large number of events. EP PerMed has established itself as a major player in the growing personalised medicine community, both in Europe and worldwide. We look forward to continuing to work together in the coming years and seeing the progress of the projects funded by EP PerMed for the future of healthcare for all citizens.

We are happy to inform you that the next Joint Transnational Call 2026 is already in the pipeline. The call will focus on cardiovascular, metabolic, and kidney diseases and will open on 25 November 2025, the day before our ICPerMed & EP PerMed Joint Conference in Prague.

The EP PerMed Consortium

EP PerMed News

27 October 2025

Preliminary Announcement for the Joint Transnational Call (JTC) 2026

EP PerMed pre-announces its Joint Transnational Call 2026 (JTC2026) “Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases” (acronym: CARMEN2026), co-funded by the European Union. The call aims to fund multinational, innovative research projects in personalised medicine. The call will be implemented in two stages with a budget of approximately 38 million euros. The full call text will be published on 25 November 2025.

27 October 2025

EP PerMed Symposium on Personalised Medicine Implementation

EP PerMed organised its first Expert Symposium on Personalised Medicine Implementation on 21 October 2025 in Bilbao (Spain). During this one-day event, high-level experts and invited participants showcased and discussed nine different examples of how European national and regional healthcare systems address the implementation of personalised medicine. They focused on the facilitating factors, as well as the gaps and challenges that can impede its adoption within these systems.

13 October 2025

Preliminary Announcement Twinning Call 2026

The Twinning Call 2026 is designed to accelerate the implementation of personalised medicine solutions or approaches from one country to another through peer-to-peer exchanges. This call offers up to 50,000 EUR to activities that facilitate the exchange of solutions or approaches in personalised medicine and build up the capacities and capabilities of one or both participating parties.

29 October 2025

New Best Practice Example: Childhood Cancer in Sweden

EP PerMed awards the title of Best Practice in Personalised Medicine to Genomic Medicine Sweden (GMS) for their national implementation of whole-genome and -transcriptome sequencing in childhood cancer in Sweden (GMS Childhood Cancer). GMS Childhood Cancer is dedicated to ensuring that every child diagnosed with cancer in Sweden has access to the most accurate and personalised diagnostics and treatments available.

09 October 2025

Winner of EP PerMed’s JTC2022 Video Competition

The winner of the JTC2022 video competition is the team of young researchers of the DAWN-AF consortium with the video ‘Digital Twins to Treat Atrial Fibrillation’.

The DAWN-AF project develops digital cardiac twins – virtual replicas of patients’ hearts – to design patient-specific ablation strategies for atrial fibrillation. By combining advanced imaging, AI-based modelling, and clinical data, the project aims to improve treatment precision, shorten recovery time, and make personalised therapies more accessible for patients worldwide.

05 February 2026

EP PerMed Training in Data Management in Personalised Medicine

EP PerMed is organising a two-day, hands-on training course on research data management (RDM), which will take place on 5 and 6 February 2026 in Paris, France. Interested candidates need to apply by providing details of their PM-related experience, achievements and publications, as well as their motivation.

The deadline for applications is 7 November 2025.

03 March 2026

EP PerMed Hackathon registrations now open!

The first EP PerMed Hackthon will take place from 3 to 4 March 2026 in Oostende, Belgium. This immersive event is designed to drive innovation and collaboration in personalised medicine. Participants will focus on the ideation of solutions that improve patient care and clinical decision making. In addition, the event will provide a platform for participants to network and build meaningful partnerships. Registration is now open!

29 October 2025

Updated Proejct Database: Eigth new Projects added

Eight outstanding projects were selected for the EP PerMed Fast Track Validation Programme 2025, an initiative designed to accelerate the development, validation, and adoption of innovative personalised medicine solutions across Europe.

Other PM-related News

26 November 2025

ICPerMed & EP PerMed Joint Conference

ICPerMed and EP PerMed are organising their first joint conference, which will take place from 26 to 27 November 2025 in Prague (Czech Republic). The conference will celebrate the 10th anniversary of the Council Conclusions on personalised medicine for patients and the first Strategic Research and Innovation Agenda on Personalised Medicine (2015).

The deadline for registration is 14 November 2025.

30 October 2025

International Personalised Medicine Perspectives

In the frame of the ICPerMed Strategic Working Group on Internationalisation, a webinar was organised on 30 October 2025 from 15:00-16:30 CET. Dr Diadelis Remirez Figueredo presented activities related to Personalised Medicine and Pharmacogenomics in Cuba. A recording is now available.

See all news